Introduction Of all people involved in the filing, prosecution and enforcement of patent rights, it could be argued that none are as important as the drafters of the initial application. Regardless of the skill and experience of the litigators, certain errors or...
The recent interim Patents Court decision of Napp Pharmaceutical Holdings Limited v (1) Dr Reddy’s Laboratories (2) Sandoz Limited (and others) [2017] EWHC 1433 (Pat) provides guidance on how the court calculates damages associated with an interim injunction and...
The applications relate to compositions for dental impression materials. Claim 1 of the granted patent read as follows: “A dental impression material comprising a base paste and a catalyst paste, wherein the base paste comprises at least one polymerizable...
Facts and History On the face of it, the Eli Lilly v Actavis case seems straightforward. Eli Lilly is the proprietor of European patent No. 1313508 which claims:- “Use of pemetrexed disodium in the manufacture of a medicament for use in combination therapy for...
Background According to Article 3(a) of the SPC Regulation (European Parliament and Council Regulation 469/2009/EC of 6 May 2009 concerning the supplementary protection certificate for medicinal products) an SPC shall be granted for a medicinal product if the product...
Recent Comments